Show simple item record

dc.contributor.authorMsomphora, Mbachi Ruth
dc.contributor.authorSørbye, Sveinung Wergeland
dc.contributor.authorGutteberg, Tore Jarl
dc.contributor.authorSkjeldestad, Finn Egil
dc.date.accessioned2014-01-22T13:55:10Z
dc.date.available2014-01-22T13:55:10Z
dc.date.issued2013
dc.description.abstractThis study has an historical prospective design by including in retrospect all screening- and follow-up tests for women aged 25 to 69 years old kept by the Department of Clinical Pathology, University Hospital of Northern Norway, Tromsø. All women with a first ASC-US/LSIL smear in 1996-98 and 2006-08 were identified and compared on outcomes such as proportion of cases resolved within 35 months of index smear and incidence of CIN2+. The Department of Clinical pathology has used an mRNA test (NorChip PreTect HPV-Proofer) since the autumn of 2005 in secondary cervical cancer screening. In triage of women with ASC-US/LSIL, the HPV mRNA test significantly reduced the time from the first abnormal cytology until biopsy and had predictive values comparable with those of repeat cytology.en
dc.identifier.citationEurogin Conference, (2013), 03.-06. Novemberen
dc.identifier.cristinIDFRIDAID 1089626
dc.identifier.urihttps://hdl.handle.net/10037/5789
dc.identifier.urnURN:NBN:no-uit_munin_5487
dc.language.isoengen
dc.publisherUiT Norges arktiske universiteten
dc.publisherUiT The Arctic University of Norwayen
dc.rights.accessRightsopenAccess
dc.subjectVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Human and veterinary science physiology: 718en
dc.subjectVDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Human og veterinærmedisinsk fysiologi: 718en
dc.titleTriage of women with ASC-US/LSIL cytology: The added value of implementation of an HPV-testen
dc.typeConference objecten
dc.typeKonferansebidragen


File(s) in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record